591.40 0.50 (0.08%)

Near 52W Low

72,611 NSE+BSE Volume

NSEDec 08, 2021 03:31 PM

New and upcoming Corporate actions, results and board meetings alerts are delivered to your inbox daily in the evening.

Board Meetings - Jubilant Pharmova Ltd.

See past and forthcoming board meetings of Jubilant Pharmova Ltd. - JUBLPHARMA, 530019

2021-10-22Quarterly Results
2021-07-23Quarterly Results
2021-06-04Audited Results & Final Dividend
2021-02-05Quarterly Results
2020-11-04Quarterly Results & OthersInter alia, to consider The proposal to issue Non-Convertible Debentures upto Rs. 100 Crore.
2020-09-04Quarterly Results
2020-05-29Audited & Quarterly ResultsInter alia, to consider Issue of Non-Convertible Debentures upto Rs. 100 Crore.
2020-02-27Interim Dividend
2020-01-31Quarterly Results
2019-10-25Quarterly Results
2019-07-26Quarterly Results
2019-05-17Audited Results & Final Dividend
2019-02-01Quarterly Results
2018-10-22Quarterly Results
2018-07-27Quarterly Results
2018-06-27OthersConsider the proposal to issue Non-Convertible Debentures up to an amount of Rs. 750 Crore.
2018-05-09Audited Results & Dividend
2018-01-17Quarterly Results
2017-10-28Quarterly Results
2017-07-18Quarterly Results
2017-05-23Audited Results & Dividend
2017-02-07Quarterly Results
2016-10-27Quarterly Results
2016-08-09Quarterly Results
2016-05-24Audited Results & Dividend
2016-02-09Quarterly Results
2015-10-29Allotment of SharesThe Board has accorded approval for raising funds through issue of Equity / GDRs / ADRs / FCCBs or other equity related instruments upto an amount of USD 200 million [Rs. 1300 crores (approx.)].
2015-08-11Quarterly Results
2015-05-12Audited Results & Dividend
2015-02-03Quarterly Results
2014-10-28Quarterly Results
2014-08-05Quarterly Results
2014-05-26Audited Results & Dividend
2014-02-06Quarterly Results
2013-10-29Quarterly Results
2013-08-01Quarterly Results
2013-05-07Audited Results & Dividend
2013-01-29Quarterly Results
2012-11-05Quarterly Results
2012-07-23Quarterly Results
2012-05-07Audited Results & Dividend
2012-02-06Quarterly Results
2011-11-01Quarterly Results
2011-08-09Quarterly Results
2011-05-10Audited Results & Dividend
2011-02-14Quarterly Results
2010-11-11Quarterly Results(Revised)
2010-07-27Quarterly Results
2010-07-08Scheme of ArrangementThe BoD has approved a SoA & Demerger among Jubilant Organosys Ltd., Speciality Molecules Ltd., Pace Marketing Specialities Ltd. & Jubilant Industries Ltd. & their respective Shareholders & Creditors.
2010-05-10Audited Results & Dividend
2010-01-21Raising of Additional Capital & OthersFor raising additional Capital through issue of Securities or other Equity related instruments or Equity related instruments to QIBs of Rs. 1000 Crs & Demerger of its Agri and Performance Polymer.
2009-10-22Raising of Capital & OthersTo consider raising of capital through issue of Equity or Equity related instruments upto Rs 500 Crs & to change the name of the Company from "Jubilant Organosys Ltd" to "Jubilant Life Sciences Ltd".
2009-07-14Quarterly Results
2009-04-28Audited Results & Dividend
2009-01-27Quarterly Results
2008-10-14Quarterly Results
2008-07-15Quarterly Results
2008-04-22Audited Results & Dividend
2008-01-30Quarterly Results(Revised)
2007-10-16Quarterly Results
2007-07-17Quarterly Results
2007-04-27Audited Results & Dividend
2007-01-16Quarterly Results
2006-10-17Quarterly Results
2006-07-18Quarterly Results
2006-04-18Accounts & Dividend
2006-01-14Quarterly Results
2005-10-28Quarterly Results
2005-10-03Allotment of equity sharesAllotment of 13689 equity shares of Rs.5/- each at a premium of Rs.813.23 per share has been made to Merill Lynch capital markets Espana S.A SV.
2005-09-06GeneralThe Board of Directors of the Company has allotted 9,90,000 equity shares of Rs 5/- each at a premium of Rs 1095/- to GA European Investments Ltd.
2005-08-04Allotment of equity sharesBoard has alloted 68447 equity shares of Rs. 5 /- each at a premium of Rs. 813.23 per share to Photon Mauritius Ltd. on conversion of a part of FCCB amounting To US $ 1250000.
2005-07-30Quarterly Results
2005-07-14Allotment of equity sharesBoard has alloted of 41,068 equity shares of Rs 5/- each at a premium of Rs 813.23 per share has been made to Merrill Lynch Capital Markets Espana SA, SV & ABN AMRO Bank NV.
2005-04-16Dividend & Accounts
2005-04-04A proposal to raise funds & OthersTo consider a proposal for acquisition of a Generic pharmaceutical Company in USA.
2005-01-29Quarterly Results
2004-10-30Quarterly Results
2004-09-21OthersTo consider investment in equity of Jubilant Clinsys Ltd and Jubilant Chemsys Ltd so as to make them wholly owned subsidiaries and to focus on the growth in clinical research and chemistry services.
2004-07-27Quarterly Results
2004-04-28Accounts & Final Dividendfor the year 31-03-2004
2004-04-22OthersConsider opportunities for business expansion including those through International acquisitions projects.
2004-02-03Othersa) To consider acquisition of equity shares in jubilant Biosys Ltd. (JBL) in order to convert JBL in to a subsidiary of the Company.
2004-01-09Quarterly Results & Interim Dividend
2003-10-11Quarterly Results
2003-07-29Quarterly Results
2003-05-09Accounts, Dividend & OthersSub Division of Equity shares and alteration of capital clause of M&A of the compay.
2003-02-05OthersBusiness expansion including those through acuisition.
2003-01-30Quarterly Results
2002-10-22Quarterly Results
2002-09-04OthersConsidering opportunities for business expansion including those through acquisition.
2002-07-17Quarterly Results & OthersMerger of Vam Leasing and Vam Investments Ltd. with the Company & Sub Division of Equity shares and alteration of capital clause of Memorandum & articles of Association of the Co.
2002-05-03Accounts & Dividend
2002-01-22Quarterly Results
2001-10-25Quarterly Results
2001-09-03OthersAllotment of Fully convertible equity warrants to promoters of the company and/or their nominees on preferential basis
2001-07-25Quarterly Results
2001-06-28Accounts & Dividend
2001-05-21OthersAllotment of Fully convertible equity warrants to promoters of the company and/or their nominees on preferential basis
2001-01-30Quarterly Results
2000-12-08Preferential OfferAllotment of Fully Convertible equity warrants to promoters on preferential basis.